Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases (Q36465283)

14 August 2017

Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases (English)

1 reference

14 August 2017

5

Caroline Seynaeve

0 references

Peter Devilee

12

object named as

Peter Devilee

0 references

Christi J. van Asperen

13

object named as

Christi J van Asperen

1 reference

14 August 2017

Petra E A Huijts

1

1 reference

14 August 2017

Maaike P G Vreeswijk

2

1 reference

14 August 2017

Karin H G Kroeze-Jansema

3

1 reference

14 August 2017

Catharina E Jacobi

4

1 reference

14 August 2017

Elly M M Krol-Warmerdam

6

1 reference

14 August 2017

Pauline M Wijers-Koster

7

1 reference

14 August 2017

Jannet C Blom

8

1 reference

14 August 2017

Karen A Pooley

9

1 reference

14 August 2017

Jan G M Klijn

10

1 reference

14 August 2017

Rob A E M Tollenaar

11

1 reference

14 August 2017

1 January 2007

1 reference

14 August 2017

Breast Cancer Research

1 reference

14 August 2017

9

1 reference

14 August 2017

6

1 reference

14 August 2017

R78

1 reference

Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

Genome-wide association study identifies novel breast cancer susceptibility loci

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

A genome wide linkage search for breast cancer susceptibility genes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

Histopathology of BRCA1- and BRCA2-associated breast cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

Ligands to FGF receptor 2-IIIb induce proliferation, motility, protection from cell death and cytoskeletal rearrangements in epithelial ovarian cancer cell lines.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

Association studies for finding cancer-susceptibility genetic variants

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

Ten genes for inherited breast cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

Prevalence of family histories of breast cancer in the general population and the incidence of related seeking of health care

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

High constant incidence in twins and other relatives of women with breast cancer.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246176

20q11.1 amplification in giant-cell tumor of bone: Array CGH, FISH, and association with outcome.

21 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR1793

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR1793

Genetic implications of bilateral breast cancer: a population based cohort study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR1793

Exposure to breast milk in infancy and adult breast cancer risk

21 January 2018

1 reference

12 December 2020

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer

1 reference

12 December 2020

Characterization of Familial Non-BRCA1/2 Breast Tumors by Loss of Heterozygosity and Immunophenotyping

1 reference

12 December 2020

Association between the CHEK2*1100delC germ line mutation and estrogen receptor status

1 reference

12 December 2020

Breast Cancer Survival and Tumor Characteristics in Premenopausal Women Carrying theCHEK2*1100delCGermline Mutation

1 reference

12 December 2020

Induction of FGF receptor 2-IIIb expression and response to its ligands in epithelial ovarian cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/BCR1793

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

17997823

1 reference